Oncology
Revealing the molecular mechanism of tumor development and identifying the matching inhibitory candidates is one important area within the cancer research.
The tumor diversity is extremely high. Therefore, cancer research belongs to the high variant research areas with manifold scientific approaches.
To match this challenge, we offer you a unique diversity of products for your oncology research and development in the academic and pharmaceutical field.
Click on the organs and learn more about cancer types
General information
Oncologists focus on the diagnosis, therapy and follow-up of cancer.
Cancer is a class of diseases in which cells start to divide uncontrollably and invade other tissues. Cancer cells can spread to other parts of the body via the blood and lymphatic system. Under physiological conditions, cell proliferation is tightly controlled by many mechanisms. In addition, the immune system is able to recognize and destroy cancer cells. If these mechanisms fail or the immune system cannot effectively destroy the cells, it can lead to a malignant tumor. Theoretically, a malignant neoplasm can occur everywhere, but there are cancers that are more often than others. For men it is the prostate and in women it is the mammary gland.
Relevant products for oncology research
Name | Price | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anti-TGIF2LX antibody (STJ190177) | Login | Anti-TGIF2LX antibody (STJ190177) | ||||||||||||||||
|
||||||||||||||||||
Anti-ARID1A antibody (1270-1350 aa) (STJ190178) | Login | Anti-ARID1A antibody (1270-1350 aa) (STJ190178) | ||||||||||||||||
|
||||||||||||||||||
Anti-CHD1 antibody (960-1040 aa) (STJ190179) | Login | Anti-CHD1 antibody (960-1040 aa) (STJ190179) | ||||||||||||||||
|
||||||||||||||||||
Anti-NKRF antibody (550-630 aa) (STJ190181) | Login | Anti-NKRF antibody (550-630 aa) (STJ190181) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAGEC1 antibody (620-700 aa) (STJ190185) | Login | Anti-MAGEC1 antibody (620-700 aa) (STJ190185) | ||||||||||||||||
|
||||||||||||||||||
Anti-ERCC2 antibody (220-300 aa) (STJ190429) | Login | Anti-ERCC2 antibody (220-300 aa) (STJ190429) | ||||||||||||||||
|
||||||||||||||||||
Anti-DUSP14 antibody (120-200 aa) (STJ190190) | Login | Anti-DUSP14 antibody (120-200 aa) (STJ190190) | ||||||||||||||||
|
||||||||||||||||||
Anti-PPP2R1A antibody (500-580 aa) (STJ190194) | Login | Anti-PPP2R1A antibody (500-580 aa) (STJ190194) | ||||||||||||||||
|
||||||||||||||||||
Anti-MAPK4 antibody (410-490 aa) (STJ190195) | Login | Anti-MAPK4 antibody (410-490 aa) (STJ190195) | ||||||||||||||||
|
||||||||||||||||||
Anti-SUPT4H1 antibody (40-120 aa) (STJ190203) | Login | Anti-SUPT4H1 antibody (40-120 aa) (STJ190203) | ||||||||||||||||
|
||||||||||||||||||
Anti-U2AF1 antibody (60-140 aa) (STJ190205) | Login | Anti-U2AF1 antibody (60-140 aa) (STJ190205) | ||||||||||||||||
|
||||||||||||||||||
Anti-FOXM1 antibody (190-270 aa) (STJ190208) | Login | Anti-FOXM1 antibody (190-270 aa) (STJ190208) | ||||||||||||||||
|
||||||||||||||||||
Anti-HSD3B2 antibody (180-260 aa) (STJ190454) | Login | Anti-HSD3B2 antibody (180-260 aa) (STJ190454) | ||||||||||||||||
|
||||||||||||||||||
Anti-EPS8 antibody (130-210 aa) (STJ190210) | Login | Anti-EPS8 antibody (130-210 aa) (STJ190210) | ||||||||||||||||
|
||||||||||||||||||
Anti-TAF10 antibody (130-210 aa) (STJ190211) | Login | Anti-TAF10 antibody (130-210 aa) (STJ190211) | ||||||||||||||||
|
||||||||||||||||||
Anti-MRPL28 antibody (1-80 aa) (STJ190458) | Login | Anti-MRPL28 antibody (1-80 aa) (STJ190458) | ||||||||||||||||
|
||||||||||||||||||
Anti-EPS15L1 antibody (350-430 aa) (STJ190299) | Login | Anti-EPS15L1 antibody (350-430 aa) (STJ190299) | ||||||||||||||||
|
||||||||||||||||||
Anti-HJURP antibody (80-160 aa) (STJ190300) | Login | Anti-HJURP antibody (80-160 aa) (STJ190300) | ||||||||||||||||
|
||||||||||||||||||
Anti-FAT1 antibody (1140-1220 aa) (STJ190301) | Login | Anti-FAT1 antibody (1140-1220 aa) (STJ190301) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF10 antibody (120-200 aa) (STJ190302) | Login | Anti-FGF10 antibody (120-200 aa) (STJ190302) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGF21 antibody (90-170 aa) (STJ190303) | Login | Anti-FGF21 antibody (90-170 aa) (STJ190303) | ||||||||||||||||
|
||||||||||||||||||
Anti-FGFBP3 antibody (110-190 aa) (STJ190304) | Login | Anti-FGFBP3 antibody (110-190 aa) (STJ190304) | ||||||||||||||||
|
||||||||||||||||||
Anti-FRAT1 antibody (130-210 aa) (STJ190306) | Login | Anti-FRAT1 antibody (130-210 aa) (STJ190306) | ||||||||||||||||
|
||||||||||||||||||
Anti-GTSE1 antibody (70-150 aa) (STJ190308) | Login | Anti-GTSE1 antibody (70-150 aa) (STJ190308) | ||||||||||||||||
|
||||||||||||||||||
Anti-IGF2BP1 antibody (10-90 aa) (STJ190314) | Login | Anti-IGF2BP1 antibody (10-90 aa) (STJ190314) | ||||||||||||||||
|